April 26, 2015
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Chipola Feather Fest Preview
Chipola Feather Fest Preview

Between April 24-26 the Great Florida Birding & Wildlife Trail festival will take place in the Chipola area of the Florida Panhandle. See what the birders are looking for.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

About the Everglades, we should...

  • Increase efforts toward restoration, esp. in light of rising sea level
  • Status quo - keep trying to fix it, as we have been
  • Get realistic. We will never restore it with millions living in South Florida.

See Results

Ballot Box
Subscribe